PACS Group, Inc. (PACS)
Official siteHEALTHCARE • MEDICAL CARE FACILITIES • NYSE
Market Cap: $7.67B
Last updated: Nov 17, 2026 at 11:06 AM ET
PACS Group, Inc. (PACS) Stock Forecast
Analysts expect PACS Group (PACS) to earn $2.62 per share in the fiscal year ending Dec 31, 2026, on revenue of $5.98B. Of 6 analysts, 6 rate the stock Buy or Strong Buy, 0 Hold and 0 Sell or Strong Sell, for a consensus of Buy. Over the last 30 days, 0 estimates for the fiscal year ending Dec 31, 2026 were revised up and 1 down.
Analyst Ratings
Scoring Strong Buy as 1 and Strong Sell as 5, the 6 ratings average 1.67, inside the Buy band from 1.5 up to 2.5. Buy and Strong Buy make up 100% of the ratings.
| Rating | Analysts | Share |
|---|---|---|
| Strong Buy | 2 | 33.3% |
| Buy | 4 | 66.7% |
| Hold | 0 | 0.0% |
| Sell | 0 | 0.0% |
| Strong Sell | 0 | 0.0% |
- Consensus
- Buy
- Total analysts
- 6
Price Target
Analyst price targets are part of paid GNG plans. See plans
Annual Estimates
From the first fiscal year below to the second, the EPS consensus rises 8.8% and revenue estimates rise 14.4%.
- Fiscal year ending Dec 31, 2026
- $2.62
- EPS consensus, revenue $5.98B
- Fiscal year ending Dec 31, 2027
- $2.85
- EPS consensus, revenue $6.84B
- Next report
- Feb 24, 2027
- Estimated
EPS range
Revenue range
| Fiscal year ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | $2.62 | $2.54 to $2.84 | 4 | $5.98B | $5.81B to $6.05B | 5 |
| Dec 31, 2027 | $2.85 | $2.68 to $3.10 | 5 | $6.84B | $6.19B to $7.35B | 6 |
Quarterly Estimates
The EPS consensus rises from $0.67 for the quarter ending Dec 31, 2026 to $0.69 for the quarter ending Mar 31, 2027.
EPS range
Revenue range
| Quarter ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | $0.67 | $0.62 to $0.75 | 8 | $1.71B | $1.62B to $1.79B | 8 |
| Mar 31, 2027 | $0.69 | $0.66 to $0.70 | 3 | $1.75B | $1.70B to $1.79B | 3 |
Estimate Revisions
Across the 3 periods below, the last 30 days brought 3 upward and 1 downward EPS revisions.
| Period | Up 30 days | Down 30 days |
|---|---|---|
| Fiscal year ending Dec 31, 2026 | 0 | 1 |
| Fiscal year ending Dec 31, 2027 | 1 | 0 |
| Quarter ending Mar 31, 2027 | 2 | 0 |
EPS Trend
Over the last 90 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has risen 4.0% from $2.52.
| Period | Now | 7 days ago | 30 days ago | 60 days ago | 90 days ago | Change |
|---|---|---|---|---|---|---|
| Fiscal year ending Dec 31, 2026 | $2.62 | $2.50 | $2.51 | $2.52 | $2.52 | +3.9% |
| Fiscal year ending Dec 31, 2027 | $2.85 | $2.74 | $2.73 | $2.71 | $2.71 | +4.9% |
| Quarter ending Mar 31, 2027 | $0.69 | $0.66 | $0.68 | $0.70 | $0.70 | -1.4% |
Frequently Asked Questions About PACS
What is the PACS stock forecast?
Consensus analyst estimates put PACS Group's EPS at $2.62 for the fiscal year ending Dec 31, 2026, on revenue of $5.98B. The consensus rating from 6 analysts is Buy.
How do analysts rate PACS stock?
Of 6 analysts covering PACS Group, 2 rate it Strong Buy, 4 Buy, 0 Hold, 0 Sell and 0 Strong Sell, for a consensus of Buy.
What EPS do analysts expect from PACS next year?
For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is $2.62, with estimates from $2.54 to $2.84 from 4 analysts. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is $2.85, with estimates from $2.68 to $3.10 from 5 analysts.
What revenue do analysts expect from PACS Group next year?
For the fiscal year ending Dec 31, 2026, the consensus revenue estimate is $5.98B, with estimates from $5.81B to $6.05B. For the fiscal year ending Dec 31, 2027, the consensus revenue estimate is $6.84B, with estimates from $6.19B to $7.35B.
How many analysts cover PACS?
6 analysts rate PACS Group stock, and 4 analysts estimate its EPS for the fiscal year ending Dec 31, 2026.
PACS pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors